1. Home
  2. LAB vs RGC Comparison

LAB vs RGC Comparison

Compare LAB & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LAB
  • RGC
  • Stock Information
  • Founded
  • LAB 1999
  • RGC 2014
  • Country
  • LAB United States
  • RGC Hong Kong
  • Employees
  • LAB N/A
  • RGC N/A
  • Industry
  • LAB Biotechnology: Laboratory Analytical Instruments
  • RGC Medicinal Chemicals and Botanical Products
  • Sector
  • LAB Industrials
  • RGC Health Care
  • Exchange
  • LAB Nasdaq
  • RGC Nasdaq
  • Market Cap
  • LAB 451.0M
  • RGC 377.5M
  • IPO Year
  • LAB 2011
  • RGC 2021
  • Fundamental
  • Price
  • LAB $0.92
  • RGC $558.05
  • Analyst Decision
  • LAB Buy
  • RGC
  • Analyst Count
  • LAB 2
  • RGC 0
  • Target Price
  • LAB $2.50
  • RGC N/A
  • AVG Volume (30 Days)
  • LAB 1.4M
  • RGC 134.9K
  • Earning Date
  • LAB 05-06-2025
  • RGC 06-20-2025
  • Dividend Yield
  • LAB N/A
  • RGC N/A
  • EPS Growth
  • LAB N/A
  • RGC N/A
  • EPS
  • LAB N/A
  • RGC N/A
  • Revenue
  • LAB $169,687,000.00
  • RGC N/A
  • Revenue This Year
  • LAB N/A
  • RGC N/A
  • Revenue Next Year
  • LAB $12.18
  • RGC N/A
  • P/E Ratio
  • LAB N/A
  • RGC N/A
  • Revenue Growth
  • LAB 33.86
  • RGC N/A
  • 52 Week Low
  • LAB $0.92
  • RGC $3.03
  • 52 Week High
  • LAB $2.68
  • RGC $560.00
  • Technical
  • Relative Strength Index (RSI)
  • LAB 35.28
  • RGC 74.56
  • Support Level
  • LAB $1.00
  • RGC $300.00
  • Resistance Level
  • LAB $1.09
  • RGC $489.00
  • Average True Range (ATR)
  • LAB 0.09
  • RGC 118.08
  • MACD
  • LAB -0.02
  • RGC 19.92
  • Stochastic Oscillator
  • LAB 0.55
  • RGC 100.00

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

About RGC Regencell Bioscience Holdings Limited

Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.

Share on Social Networks: